Fulgent Genetics

(NASDAQ) FLGT

Current Price$15.96

Market Cap$453.27M

Since IPO (2016)+74%

5 Year-79%

1 Year-14%

1 Month+1%

Fulgent Genetics Financials at a Glance

Market Cap

$453.27M

Revenue (TTM)

$320.35M

Net Income (TTM)

$73.81M

EPS (TTM)

$-2.40

P/E Ratio

-6.66

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$15.96

Volume

48,678

Open

$15.00

Price

$15.96

Volume

48,678

Open

$15.00

Previous Close

$15.96

Daily Range

$14.94 - $15.96

52-Week Range

$13.46 - $31.04

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$15.96

Volume

48,678

Open

$15.00

Previous Close

$15.96

Daily Range

$14.94 - $15.96

52-Week Range

$13.46 - $31.04

FLGT News

Page 1

FLGT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fulgent Genetics

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

1,344

CEO

Ming Hsieh

Website

www.fulgentgenetics.com

Headquarters

El Monte, CA 91780, US

FLGT Financials

Key Financial Metrics (TTM)

Gross Margin

38%

Operating Margin

-33%

Net Income Margin

-23%

Return on Equity

-7%

Return on Capital

-10%

Return on Assets

-6%

Earnings Yield

-15.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$453.27M

Shares Outstanding

28.40M

Volume

48.68K

Avg. Volume

626.31K

Financials (TTM)

Gross Profit

$130.88M

Operating Income

$91.10M

EBITDA

$45.83M

Operating Cash Flow

$101.64M

Capital Expenditure

$22.57M

Free Cash Flow

$124.21M

Cash & ST Invst.

$336.08M

Total Debt

$7.68M

Fulgent Genetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$71.14M

-3.2%

Gross Profit

$19.46M

-31.4%

Gross Margin

27.35%

N/A

Market Cap

$453.27M

N/A

Market Cap/Employee

$345.22K

N/A

Employees

1,313

N/A

Net Income

$24.83M

-115.3%

EBITDA

$28.62M

-394.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$266.13M

-14.9%

Accounts Receivable

$75.74M

-5.8%

Inventory

$770.00K

-91.1%

Long Term Debt

$7.48M

+27.9%

Short Term Debt

$2.69M

+48.7%

Return on Assets

-6.38%

N/A

Return on Invested Capital

-9.93%

N/A

Free Cash Flow

$1.90M

+120.7%

Operating Cash Flow

$7.10M

+260.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PACBPacific Biosciences of California, Inc.

PACBPacific Biosciences of California, Inc.$1.41-14.55%

VALNValneva SE

VALNValneva SE$5.59+0.54%

MYGNMyriad Genetics, Inc.

MYGNMyriad Genetics, Inc.$4.29+4.89%

PSNLPersonalis, Inc.

PSNLPersonalis, Inc.$5.98-0.17%

CSTLCastle Biosciences, Inc.

CSTLCastle Biosciences, Inc.$19.83+3.07%

AVXLAnavex Life Sciences Corp.

AVXLAnavex Life Sciences Corp.$3.22+3.21%

ARVNArvinas, Inc.

ARVNArvinas, Inc.$10.11-0.79%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

BBBlackBerry

BBBlackBerry$6.37+0.04%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.01+0.26%

Questions About FLGT

What is the current price of Fulgent Genetics?

Fulgent Genetics is trading at $15.96 per share.

What is the 52-week range for Fulgent Genetics?

Over the past 52 weeks, Fulgent Genetics has traded between $13.46 and $31.04.

How much debt does Fulgent Genetics have?

As of the most recent reporting period, Fulgent Genetics reported total debt of $10.17M.

How much cash does Fulgent Genetics have on hand?

Fulgent Genetics reported $23.40M in cash and cash equivalents in its most recent financial results.

What is Fulgent Genetics’s dividend yield?

Fulgent Genetics does not currently have a dividend yield.

Fulgent Genetics

Fulgent Genetics Financials at a Glance

FLGT News

Fulgent Genetics: A Risky Bet or a Hidden Gem?

Fulgent (FLGT) Q2 Revenue Jumps 16%

Why Fulgent Genetics Stock Was Crushing It on Friday

Investing in Genetic Testing Stocks

Fulgent Genetics Revenue Tops Estimates

Fulgent Genetics: EPS Exceeds Forecast

Fulgent Genetics Q2: Core Revenue Grows, but Profitability Is Still an Issue

Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist

FLGT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Fulgent Genetics

FLGT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Fulgent Genetics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FLGT

What is the current price of Fulgent Genetics?

What is the 52-week range for Fulgent Genetics?

How much debt does Fulgent Genetics have?

How much cash does Fulgent Genetics have on hand?

What is Fulgent Genetics’s dividend yield?

Premium Investing Services